Year: 2025

At the Annual General Meeting of Festi on March 5, 2025, the shareholders approved to authorize the Board of Directors, pursuant to Article 55 of the Act on Public Limited Companies No. 2/1995, to purchase up to 10% of issued shares in the company. The purpose of the program is to reduce the company‘s share capital and/or to enable the company to meet its obligations according to stock option agreements with employees. The Board of Directors of Festi has, based on this mandate issued by the Annual General Meeting, decided on the execution of a buyback program. The aim is to buy back own shares for the maximum amount of 2,500,000 shares which is 0.80% of total shares but the amount of the buyback will not exceed ISK 800 million in total purchase price. The buyback program will be executed in stages, with the maximum amount of shares set...

VANCOUVER, British Columbia, June 27, 2025 (GLOBE NEWSWIRE) — Rio Silver Inc. (the “Company” or “Rio Silver”) (TSX.V: RYO) (OTC: RYOOF) announces that, further to the announcement on May 1, 2025, it will consolidate (the “Consolidation”) its common shares on the basis of five pre-Consolidation common shares for one post-Consolidation share. The Company expects that the TSX Venture Exchange (the “Exchange”) will issue a bulletin in short order, confirming that the Company’s common shares will then commence trading on a post-Consolidation basis effective on or about the opening of trading on Thursday, July 3, 2025. There will be no change to the Company’s name or trading symbol. The new CUSIP and ISIN numbers for the post-Consolidation shares are 76721A113 and CA76721A1131, respectively. No...

Boca Raton, Florida, June 27, 2025 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has entered into securities purchase agreements with two healthcare focused institutional investors for the purchase and sale of 3,000,000 shares of its common stock in a registered direct offering (the “Offering”) at a purchase price of $6.30 per share, priced at-the-market under Nasdaq rules. The closing of the Offering is expected to occur on or about June 30, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the Offering are expected to be approximately $19 million, before deducting placement agent fees and other estimated offering expenses. The Company intends to use the net proceeds from the...

The leading hard cider brand is transforming daily annoyances into fiery refreshment with a bold new cider infused with real anger from real peopleANGRY ORCHARD® HARD CIDER WILL CREATE ‘WORLD’S ANGRIEST CIDER’ USING FANS’ EVERYDAY FRUSTRATIONS AS KEY INGREDIENTThe leading hard cider brand is transforming daily annoyances into fiery refreshment with a bold new cider infused with real anger from real peopleWALDEN, N.Y., June 27, 2025 (GLOBE NEWSWIRE) — Whether it’s summer beach traffic, ads interrupting your music or your boss sending you work emails after hours, the world is a goldmine of things that make us angry.   This summer, the traditionally sweet cider of Angry Orchard is getting a surprisingly spicy new flavor with the introduction of the ‘World’s Angriest Cider.’ The key ingredient? The real-life, everyday frustrations...

PHILADELPHIA, June 27, 2025 (GLOBE NEWSWIRE) — Brandywine Realty Trust (the “Company”) (NYSE: BDN) announced today that its operating partnership, Brandywine Operating Partnership, L.P. (the “Operating Partnership”), has closed its previously announced underwritten public offering of $150 million of its 8.875% guaranteed notes due 2029 with a re-offer yield of 7.039% (the “Notes”). The Notes are part of the same series as the Operating Partnership’s outstanding 8.875% guaranteed notes due 2029, $400 million of which were originally issued on April 12, 2024, for all purposes. The Operating Partnership intends to use the net proceeds from the offering to repay outstanding borrowings under the Operating Partnership’s $600 million unsecured revolving credit facility, to fund a partial repayment of its secured debt and for general corporate...

June 27, 2025 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulation of the AMFDate   Shares   Voting rightsTheoretical* Exercisable**31 May 2025 43,203,225 48,990,941 48,941,337*This number is calculated on the basis of all the shares to which voting rights are attached, including shares which voting rights have been suspended, in accordance with Article 223-11 of the AMF general regulation related to the calculation of the crossing of thresholds with regard to the number of voting rights. **For information purposes, this number excludes the shares which voting rights have been suspended. The information is also available in the « Regulated Information » section of the Ipsos website: https://www.ipsos.com/en/regulated-informations/en....

Siili Solutions Plc       Announcement  27.6.2025          Siili Solutions Plc: Share Repurchase 27.6.2025       In the Helsinki Stock Exchange         Trade date           27.6.2025  Bourse trade         Buy  Share                  SIILI  Amount             1 100 SharesAverage price/ share    6,3309 EURTotal cost            6 963,99 EUR          Siili Solutions Plc now holds a total of 19 949 sharesincluding the shares repurchased on 27.6.2025       The share buybacks are executed in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5and the Commission Delegated Regulation (EU) 2016/1052.     On behalf of Siili Solutions Plc         Nordea Bank Oyj         Sami Huttunen Ilari Isomäki       Further...

Lassila & Tikanoja plcStock Exchange Release 27 June 2025 at 5.50 pm Lassila & Tikanoja plc has refinanced its long-term debt financing Lassila & Tikanoja plc has today, 27 June 2025, entered into unsecured financing arrangements consisting of a EUR 35 million term loan and a EUR 15 million term loan and revolving credit facilities agreement with OP Corporate Bank Plc, as well as a EUR 40 million revolving credit facility agreement with Danske Bank A/S, Finland Branch. The financing arrangements are part of Lassila & Tikanoja plc’s refinancing of its long-term debt financing that was originally set to mature in 2026. The EUR 35 million term loan, the EUR 15 million term loan and revolving credit facilities, and the EUR 40 million revolving credit facility will mature in the second quarter of 2028, with a two-year...

STOCKHOLM, SWEDEN June 27, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics carries out a fully secured rights issue of units of SEK 28.3 million. The proceeds from the rights issue are intended to finance the continued development of the drug candidate sevuparin in chronic kidney disease with anemia. On June 26 2025, the portfolio company Modus Therapeutics, listed on Nasdaq First North Growth Market, announced that the company is carrying out a fully secured rights issue of units that, upon full subscrption will provide the company with SEK 28.3 million before issue costs. The rights issue is subject to approval by an extraordinary general meeting held on July 29, 2025. The purpose of the rights issue is to provide capital for the continued clinical development of...